Sonnet Biotherapeutics Holdings, Inc. [BURG]

Source: 

Company Overview

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage, oncology-focused biotechnology company with a proprietary platform for innovating biologic medicines of single or bifunctional action. Known as FHAB, the technology utilizes a fully human single chain antibody fragment that binds to and “hitch-hikes” on human serum albumin for transport to target tissues.